ILDR2

ILDR2 분자 정보

영어 이름Immunoglobulin-like domain-containing receptor 2시판 약물 수0
임상 약물 수1표적 별명Immunoglobulin-like domain-containing receptor 2,ILDR2,C1orf32,Immunoglobulin-Like Domain Containing Receptor 2,LISCH-Like,DJ782G3.1,Immunoglobulin Like Domain Containing Receptor 2,Chromosome 1 Open Reading Frame 32
최고 연구 개발 단계Phase 1 Clinical
영어 이름Immunoglobulin-like domain-containing receptor 2
표적 별명Immunoglobulin-like domain-containing receptor 2,ILDR2,C1orf32,Immunoglobulin-Like Domain Containing Receptor 2,LISCH-Like,DJ782G3.1,Immunoglobulin Like Domain Containing Receptor 2,Chromosome 1 Open Reading Frame 32
시판 약물 수0
임상 약물 수1
최고 연구 개발 단계Phase 1 Clinical

ILDR2 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • Human (1)

  • 태그

    Fc Tag (1)

  • 마커

    Unconjugated (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
IL2-H5259
Human
HEK293
Human ILDR2 Protein, Fc Tag
총 수량1
  • 1

ILDR2분자 배경

ILDR2 belongs to the immunoglobulin superfamily. May be involved in lipid homeostasis and ER stress pathways. ILDR2 as a novel B7-like protein with robust T cell inhibitory activity, expressed in immune cells and in immune-privileged and inflamed tissues. A fusion protein, consisting of ILDR2 extracellular domain with an Fc fragment, that binds to a putative counterpart on activated T cells showed a beneficial effect in the collagen-induced arthritis model and abrogated the production of proinflammatory cytokines and chemokines in autologous synovial-like cocultures of macrophages and cytokine-stimulated T cells. Collectively, these findings point to ILDR2 as a novel negative regulator for T cells, with potential roles in the development of immune-related diseases, including autoimmunity and cancer.

ILDR2분자 별명

ILDR2,C1orf32

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
BapotulimabBAY-1905254Phase 1 ClinicalCompugen LtdSolid tumours; Squamous Cell Carcinoma of Head and Neck
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호